Zostavax Sospensione iniettabile

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

virus varicellae vivus

MAH:

MSD Merck Sharp & Dohme AG

ATC_code:

J07BK02

INN:

virus varicellae vivus

pharmaceutical_form:

Sospensione iniettabile

composition:

Vaccinum attenuatum: virus varicellae vivus min. 19400 U., saccharum, gelatina hydrolysata, ureum, natrii chloridum, natrii hydrogenoglutamas monohydricus, dinatrii phosphas, kalii dihydrogenophosphas, kalii chloridum, neomycinum, pro vitro. Solvens: aqua ad iniectabile.

class:

B

therapeutic_group:

Vaccini

therapeutic_area:

Immunizzazione attiva contro l'Herpes Zoster e la Nevralgia post-erpetica, a partire dai 50. Compleanno

authorization_date:

2007-02-22